Top GLP-1 Legal & Regulatory Concerns for Investors Miranda Schmalfuhs In this part of his Pharmaceutical Executive video interview, Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses the top legal and regulatory concerns for investors considering when financing companies developing or marketing GLP-1 drugs
Where on the rubber stopper should I insert the needle
Slices were obtained from postnatal day 5 rats and were biolistically transfected with the red fluorescent dye Tomato to visualze dendritic structues
GLP-1 is a hormone released in the intestines in response to food intake, and it plays a pivotal role in regulating blood sugar levels, insulin secretion, and satiety
One such challenge is that GLP-1s are designed to be taken for the long-term, however, up to 68% of people have discontinued their treatment as soon as one year later